|
National Stock Number(NSN): 6505-00-582-5217 (6505005825217, 005825217)
| NIIN: |
00-582-5217 |
Item Name: |
POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE |
INC: |
48876
|
| FSC: |
6505
|
Assignment Date: |
Jan-01-1963 |
CRIT: |
X |
IIG: |
48876 |
| ISC: |
5 |
Date Standardized: |
Feb-01-1975 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9270 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
98 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
I0N0TRATE6653 |
60060
|
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION |
H |
3 |
1 |
6 |
75 |
|
|
|
|
|
|
|
I0N0TRATE6653 |
70048
|
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV |
H |
5 |
9 |
6 |
75 |
3 |
B |
|
|
|
|
|
NDC00338-0327-62 |
04687
|
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES |
H |
3 |
2 |
4 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
149.000 MILLIGRAMS POTASSIUM CHLORIDE EQUIVALENT PER MILLILITER |
| AKJQ |
PHARMACEUTICAL VEHICLE TYPE |
ANY ACCEPTABLE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
20.000 MILLILITERS |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|